Skip to main content
. 2020 Nov 24;38:100824. doi: 10.1016/j.nmni.2020.100824

Table 5.

Antibiotic-resistance pattern of the Escherichia coli strains isolated from fertile and infertile women

Groups of women (No. of UPEC strains) Antibiotic-resistance pattern (%)
Kana TE30 S10 C30 SXT GM10 NFXS CF30 CIP5 TMP5 F/M300 AM10 NLX imp AM30 MZL Cef30 pip CTMX CLN CFTI tob
Infertile women History of UTIs (16) 9 16 8 2 11 16 10 9 11 10 9 16 6 3 10 5 6 6 8 9 7 5
No history of UTIs (10) 2 9 5 2 5 4 5 2 1 5 1 1 1 1 4 5 3
Total (26) 11 (42.30) 25 (96.15) 13 (50) 2 (7.69) 13 (50) 21 (80.76) 14 (53.84) 14 (53.84) 13 (50) 11 (42.30) 9 (34.61) 21 (80.76) 7 (26.92) 3 (11.53) 11 (42.30) 6 (23.07) 7 (26.92) 6 (23.07) 12 (46.15) 14 (53.84) 10 (38.46) 5 (19.23)
Fertile women History of UTIs (13) 7 12 6 1 9 12 8 7 9 9 8 12 2 1 7 4 3 4 3 4 4 2
No history of UTIs (5) 1 2 1 1 1 1 2 2 1 2 1
Total (18) 8 (44.44) 14 (77.77) 7 (38.88) 1 (5.55) 10 (55.55) 13 (72.22) 9 (50) 9 (50) 9 (50) 9 (50) 8 (44.44) 14 (77.77) 2 (11.11) 1 (5.55) 7 (38.88) 4 (22.22) 3 (16.66) 4 (22.22) 4 (22.22) 6 (33.33) 5 (27.77) 2 (11.11)
Total (44) 19 (43.18) 39 (88.63) 20 (45.45) 3 (6.81) 23 (52.27) 34 (77.27) 23 (52.27) 23 (52.27) 22 (50) 20 (45.45) 17 (38.63) 35 (79.54) 9 (20.45) 4 (9.09) 18 (40.90) 10 (22.72) 10 (22.72) 10 (22.72) 16 (36.36) 20 (45.45) 15 (34.09) 7 (15.90)

Abbreviations: UPEC, uropathogenic Escherichia coli; UTI, urinary tract infection.

a

Kan, kanamycin (1000 μg/disc), TE30, tetracycline (30 μg/disc); S10, streptomycin (10 μg/disc); C30, chloramphenicol (30 μg/disc); SXT, sulfamethoxazole (25 μg/disc); GM10, gentamycin (10 μg/disc); NFX5, enrofloxacin (5 μg/disc); CF30, cephalothin (30 μg/disc); CIP5, ciprofloxacin (5 μg/disc); TMP5, trimethoprim (5 μg/disc); F/M300, nitrofurantoin (300 μg/disc); AM10, ampicillin (10 μg/disc); NLX, nalidixic acid (30 μg/disc); imp, imipenem (30 μg/disc); AM30, amikacin (30 μg/disc); MZL, mezlocillin (30 μg/disc); Cef30, cefotaxime (30 μg/disk); pip, piperacillin (30 μg/disk); CTMX, cotrimoxazole (30 μg/disk); CLN, clindamycin (2 μg/disc); CFTI, ceftriaxone (30 μg/disc); tob, tobramycin (30 μg/disc).